Research and experimental development on natural sciences and engineering
ROLOGEN AS
Revenue 2024
NOK 0
Operating profit
NOK −9,000
Equity
NOK 4.6m
Incorporated
2019
Share capital
NOK 50,000
Roles
Daglig lederRoger Løvlie
Styrets lederRoger Løvlie
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ROGER LØVLIE | 100.0% | 50000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| LIANLO AS | Active | 100.0% | 30000.000000 |
| COLOALERT AS | Active | 33.3% | 277451.000000 |
| UNI TARGETING RESEARCH AS | Active | 20.0% | 85274242.000000 |
| BRACOM AS | Active | 1.9% | 1200.000000 |
| CIMON MEDICAL AS | Active | 0.1% | 1753.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.